Kenneth M. Kozloff, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Molecular and Cellular Biomechanics, Organ and Whole Body Biomechanics, Tissue Engineering and Regenerative MedicineGoogle:
"Kenneth Kozloff"Mean distance: 9.03
Parents
Sign in to add mentor| Steven A. Goldstein | grad student | 2005 | University of Michigan | |
| (Influence of a collagen mutation of the mechanical nature of bone: Governing factors in a disease model for osteogenesis imperfecta type IV.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Surowiec RK, Battle LF, Ward FS, et al. (2019) A Xenograft Model to Evaluate the Bone Forming Effects of Sclerostin Antibody in Human Bone Derived from Pediatric Osteogenesis Imperfecta Patients. Bone. 115118 |
| Scheiber AL, Barton DK, Khoury BM, et al. (2019) Sclerostin Antibody-Induced Changes in Bone Mass are Site Specific in Developing Crania. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Olvera D, Stolzenfeld R, Fisher E, et al. (2019) Pamidronate Administration during Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Olvera D, Stolzenfeld R, Marini JC, et al. (2018) Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Marini JC, Forlino A, Bächinger HP, et al. (2017) Osteogenesis imperfecta. Nature Reviews. Disease Primers. 3: 17052 |
| Perosky JE, Khoury BM, Jenks TN, et al. (2016) Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model. Bone |
| Sinder BP, Lloyd WR, Salemi JD, et al. (2016) Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age. Bone |
| Mertz EL, Makareeva E, Mirigian LS, et al. (2016) Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model Matrix Biology |
| Donneys A, Nelson NS, Perosky JE, et al. (2015) Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation. Bone |
| Geister KA, Brinkmeier ML, Cheung LY, et al. (2015) LINE-1 Mediated Insertion into Poc1a (Protein of Centriole 1 A) Causes Growth Insufficiency and Male Infertility in Mice. Plos Genetics. 11: e1005569 |